Benefits
Cellular Energy and Mitochondrial Support
Pentadecanoic acid integrates into mitochondrial membranes and has been associated with improved mitochondrial respiratory function in cell-based assays. This may support cellular energy production, particularly in tissues with high metabolic demand such as muscle, brain, and liver.
Inflammatory Tone Modulation
C15:0 has demonstrated anti-inflammatory activity across multiple cell systems, including reduced production of pro-inflammatory cytokines. This supports its positioning as a fatty acid that may help maintain healthy inflammatory balance in aging and stressed tissues.
Cardiometabolic Marker Support
Observational studies have linked higher circulating C15:0 levels to favorable cardiometabolic profiles, including healthier triglyceride, glucose, and inflammatory markers. The data are correlational but biologically consistent with mechanistic findings in cells.
Longevity Pathway Activation
C15:0 has been shown to activate AMPK and PPAR signaling — pathways involved in cellular stress resistance, fatty acid oxidation, and longevity-associated processes. These mechanisms position the fatty acid within the broader nutraceutical landscape of metabolic-health and healthy-aging support.
Antifibrotic Activity
Cell-based work suggests C15:0 may help dampen fibrotic responses in liver and other tissues by modulating TGF-beta signaling and inflammatory cascades. The translational relevance to human metabolic-associated fatty liver disease is an active area of investigation.
Lower LDL cholesterol, a blood lipid marker, in one diet trial
In a 12-week double-blind trial in 88 Chinese women with fatty liver, C15:0 added to a Mediterranean-style diet lowered LDL cholesterol more than the diet alone; insulin and HbA1c fell in every group with weight loss. In 30 young adults with overweight or obesity, 200 mg a day for 12 weeks did not change glucose, insulin or LDL versus placebo. Lower diabetes risk with higher blood C15:0 is observational and tracks dairy fat intake.
Mechanism of action
Membrane Saturation and Integrity
As a saturated odd-chain fatty acid, C15:0 incorporates into phospholipid membranes and may stabilize membrane fluidity in ways differentiated from even-chain saturates. This structural role is hypothesized to influence membrane-protein function and cellular resilience.
AMPK Pathway Activation
C15:0 has been reported to activate AMP-activated protein kinase, the cellular energy sensor that promotes mitochondrial biogenesis, fatty acid oxidation, and metabolic flexibility. AMPK activation underlies many longevity-associated interventions.
PPAR-alpha and PPAR-delta Signaling
The fatty acid binds and modulates peroxisome proliferator-activated receptors, transcription factors that orchestrate fatty acid oxidation, lipid handling, and anti-inflammatory gene programs. This receptor activity is one proposed substrate for C15:0's metabolic effects.
Anti-Inflammatory Cytokine Modulation
C15:0 reduces expression and release of inflammatory cytokines including TNF-alpha and IL-6 in stressed cells. This anti-inflammatory signature has been observed across multiple cell types and disease-relevant models.
Clinical trials
Cell-based screening of pentadecanoic acid across 12 primary human disease systems, comparing it head-to-head with omega-3 EPA on inflammatory, immune, fibrotic, and metabolic endpoints. (Venn-Watson et al, PLoS One)
Primary human cell-based disease models (in vitro).
C15:0 showed broader and safer clinically-relevant activities than omega-3 across the 12 systems tested, including stronger anti-inflammatory and antifibrotic profiles with fewer off-target effects. Provides mechanistic basis for promoting C15:0 as a candidate essential fatty acid distinct from omega-3 fatty acids.
Foundational paper proposing C15:0 as a previously unrecognized essential dietary fatty acid based on convergent evidence from cell assays, animal studies, and human observational data. (Venn-Watson, Lumpkin, Dennis, Sci Rep)
Multi-system integrated analysis: cell, animal, human observational data.
Pentadecanoic acid attenuated inflammation, anemia, dyslipidemia, and fibrosis across the systems analyzed, with proposed mitochondrial-repair mechanisms. Authors argue the convergent evidence supports essentiality status — a designation that remains under active scientific discussion.
Mini-review summarizing accumulating cellular, animal, and human data on pentadecanoic acid's biological roles and the ongoing debate about its candidate essentiality status. (Ciesielski et al, Biochimie)
Narrative review of literature.
The review surveys C15:0's metabolic and anti-inflammatory activity but notes the essentiality framework remains controversial and requires independent confirmation. It outlines what additional human trial evidence would be needed to formally classify C15:0 as essential.